Machine Learning Based Risk Prediction for Major Adverse Cardiovascular Events

Michael Schrempf1, Diether Kramer1, Stefanie Jauk1,2

  • 1Steiermärkische Krankenanstaltengesellschaft m. b. H., Graz, Austria.

Insights

Machine learning models predict the 5-year risk of major adverse cardiovascular events (MACE) like heart attack and stroke. A random forest model showed excellent performance, identifying high-risk patients for early intervention.

Area of Science:

  • Cardiovascular medicine
  • Medical informatics
  • Machine learning in healthcare

Background:

  • Major adverse cardiovascular events (MACE), including myocardial infarction and stroke, lead to significant hospitalizations and mortality.
  • Early identification of at-risk patients is crucial for implementing preventive interventions.
  • Developing robust risk prediction tools is essential for improving patient outcomes.

Purpose of the Study:

  • To develop and evaluate machine learning models for predicting the 5-year risk of MACE.
  • To leverage electronic medical record data for comprehensive cardiovascular risk assessment.
  • To identify key features for accurate MACE prediction.

Main Methods:

  • Utilized electronic medical records from over 128,000 patients, with 29,262 diagnosed with MACE.
  • Applied feature selection techniques (filter and embedded methods) to identify 826 relevant features.
  • Trained and evaluated various machine learning models on the prepared dataset.

Main Results:

  • A random forest model demonstrated superior calibration and discriminative ability.
  • The best performing model achieved an Area Under the Receiver Operating Characteristic curve (AUROC) of 0.88 on a test dataset.
  • The models showed excellent predictive performance in the evaluated test data.

Conclusions:

  • The developed machine learning models exhibit excellent performance for 5-year MACE risk prediction.
  • Further prospective studies are required to validate the clinical utility and benefit of these models.
  • These models hold potential for early detection and prevention of cardiovascular events.
Abstract

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.6K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
581
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
481
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
866
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
441
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
218